The role of neuropeptide-Y in nandrolone decanoate-induced attenuation of antidepressant effect of exercise

PLoS One. 2017 Jun 5;12(6):e0178922. doi: 10.1371/journal.pone.0178922. eCollection 2017.

Abstract

Since the increased prevalence of anabolic androgenic steroids abuse in last few decades is usually accompanied by various exercise protocols, the scope of our study was to evaluate the effects of chronic nandrolone decanoate administration in supraphysiological dose and a prolonged swimming protocol (alone and simultaneously with nandrolone decanoate) on depressive state in male rats. Simultaneously, we investigated the possible alterations in neuropeptide Y (NPY) content in blood and the hippocampus, in order to determine the role of NPY in the modulation of depressive-like behavior.Exercise induced antidepressant effects in tail suspension test (decrease of the total duration of immobility), as well as significant increase in the number of hippocampal NPY-interneurons in CA1 region. Chronic nandrolone decanoate treatment attenuated the beneficial antidepressant effects of exercise as measured by the tail suspension test parameters. Simultaneously, nandrolone decanoate treatment resulted in diminution of NPY content both in blood (decreased serum levels) and in hippocampus (the significant decrease in NPY expression in all three investigated hippocampal regions-CA1, CA2/3 and DG). Our findings indicate that alterations in serum and hippocampal NPY contents may underlie the changes in depressive state in rats. The exercise was beneficial as it exerted antidepressant effect, while chronic nandrolone decanoate treatment resulted in depressive-like behavior. Furthermore, the behavioral indicators of depression showed strong correlations with the serum levels and the hippocampal content of NPY.

MeSH terms

  • Anabolic Agents / adverse effects*
  • Animals
  • Behavior, Animal / drug effects
  • CA1 Region, Hippocampal / drug effects
  • CA1 Region, Hippocampal / metabolism
  • CA2 Region, Hippocampal / drug effects
  • CA2 Region, Hippocampal / metabolism
  • CA3 Region, Hippocampal / drug effects
  • CA3 Region, Hippocampal / metabolism
  • Dentate Gyrus / drug effects
  • Dentate Gyrus / metabolism
  • Depression / genetics
  • Depression / metabolism*
  • Depression / physiopathology
  • Gene Expression / drug effects*
  • Immobilization
  • Interneurons / drug effects
  • Interneurons / metabolism
  • Male
  • Nandrolone / adverse effects
  • Nandrolone / analogs & derivatives*
  • Nandrolone Decanoate
  • Neuropeptide Y / antagonists & inhibitors
  • Neuropeptide Y / genetics
  • Neuropeptide Y / metabolism*
  • Physical Conditioning, Animal*
  • Rats
  • Rats, Wistar
  • Swimming

Substances

  • Anabolic Agents
  • Neuropeptide Y
  • Nandrolone
  • Nandrolone Decanoate

Grants and funding

This work was supported by Faculty of Medical Sciences, University of Kragujevac, Serbia (JP 01/13) and Ministry of Education, Science, and Technological Development of Serbia(Grant No 175061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.